Storgate’s Pfizer PFE Stock Holding History

Storgate’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72M	Buy	71,316 +39,199	+122%	+$1.03M	0.36%	50
2026 Q1	$902K	Buy	32,117 +676	+2%	+$18K	0.71%	21
2025 Q4	$783K	Buy	+31,441	New	+$793K	0.64%	23

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Storgate's PFE Position: Q2 2026 in Review

Storgate increased its Pfizer (PFE) stake by 122% in Q2 2026, buying an estimated $1.03M and bringing the position to 71,316 shares worth $1.72M. The position accounts for 0.36% of the portfolio, ranked #50.

Storgate first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Storgate held 71,316 shares of Pfizer worth $1.72M as of Q2 2026.
Storgate bought 39,199 Pfizer shares in Q2 2026, an estimated $1.03M.
Pfizer made up 0.36% of Storgate's portfolio in Q2 2026, its #50 holding.
Storgate first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Storgate's 13F filing for Q2 2026, filed 12 Aug 2026.